Gradient Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-400
Closed -$71K 121
2022
Q1
$71K Buy
+400
New +$68.1K 0.03% 123

Other funds holding JNJ

Gradient Capital Advisors's JNJ Position: Q2 2026 in Review

Gradient Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, selling an estimated $14.9K and leaving 5,325 shares worth $1.35M. The position accounts for 0.31% of the portfolio, ranked #63.

Gradient Capital Advisors first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.53M in Q4 2022. 1,028 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gradient Capital Advisors held 5,325 shares of Johnson & Johnson worth $1.35M as of Q2 2026.
  • Gradient Capital Advisors sold 64 Johnson & Johnson shares in Q2 2026, an estimated $14.9K.
  • Johnson & Johnson made up 0.31% of Gradient Capital Advisors's portfolio in Q2 2026, its #63 holding.
  • Gradient Capital Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • Gradient Capital Advisors's Johnson & Johnson position peaked at $1.53M in Q4 2022.
  • 1,028 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gradient Capital Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.